Alloimmunization
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics (NCT03288012) | Sanquin Research & Blood Bank Divisions | 2017-09-20 |
Track Alloimmunization automatically
Every clearance here is in the API, with alerts when new ones post.